T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$3.17B |
| 2 |
Nike
NKE
|
+$1.94B |
| 3 |
Bank of America
BAC
|
+$1.84B |
| 4 |
FedEx
FDX
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.61B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.1B |
| 2 |
Fortive
FTV
|
+$2.54B |
| 3 |
Linde
LIN
|
+$1.53B |
| 4 |
Alibaba
BABA
|
+$1.35B |
| 5 |
Willis Towers Watson
WTW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.99% |
| 2 | Healthcare | 16.87% |
| 3 | Consumer Discretionary | 15.81% |
| 4 | Financials | 11.47% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Guidewire Software
GWRE
$15.2B
| $17.4M | ﹤0.01% |
166,596
-57,497
| -26% | -$6.46M |
|
1177
Enpro
NPO
$7.12B
| $17.3M | ﹤0.01% |
306,498
-7,692
| -2% | -$415K |
|
|
GTHX
1178
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $17.3M | ﹤0.01% |
1,495,019
-82,177
| -5% | -$1.36M |
|
|
USX
1179
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $17.3M | ﹤0.01% |
2,090,104
| – | – |
|
1180
National CineMedia
NCMI
$252M
| $17.3M | ﹤0.01% |
635,506
-3,349
| -0.5% | -$105K |
|
1181
Kimbell Royalty Partners
KRP
$1.53B
| $17.2M | ﹤0.01% |
2,812,134
-275,061
| -9% | -$2.22M |
|
1182
UDR
UDR
$12B
| $17.1M | ﹤0.01% |
525,903
-14,124
| -3% | -$496K |
|
1183
Gray Television
GTN
$520M
| $17.1M | ﹤0.01% |
1,238,599
-360,665
| -23% | -$5.27M |
|
1184
Essential Properties Realty Trust
EPRT
$6.62B
| $17M | ﹤0.01% |
928,749
+884,461
| +1,997% | +$15M |
|
1185
Columbia Financial
CLBK
$1.21B
| $17M | ﹤0.01% |
1,528,231
+852
| +0.1% | +$10.1K |
|
1186
Oil-Dri
ODC
$1.27B
| $16.9M | ﹤0.01% |
945,882
-140,378
| -13% | -$2.51M |
|
1187
Ligand Pharmaceuticals
LGND
$5.76B
| $16.8M | ﹤0.01% |
282,931
-191,724
| -40% | -$13.1M |
|
|
FOLD
1188
DELISTED
Amicus Therapeutics
FOLD
| $16.8M | ﹤0.01% |
1,191,337
+70,084
| +6% | +$1.02M |
|
|
ONEM
1189
DELISTED
1Life Healthcare
ONEM
| $16.7M | ﹤0.01% |
+590,020
| New | +$18.6M |
|
1190
Texas Roadhouse
TXRH
$14.1B
| $16.7M | ﹤0.01% |
275,029
-132,658
| -33% | -$7.77M |
|
1191
Albemarle
ALB
$15.4B
| $16.5M | ﹤0.01% |
184,643
-4,384
| -2% | -$388K |
|
1192
Seres Therapeutics
MCRB
$47.4M
| $16.5M | ﹤0.01% |
29,108
+27,799
| +2,124% | +$9.24M |
|
1193
Iron Mountain
IRM
$37B
| $16.4M | ﹤0.01% |
613,180
-6,657
| -1% | -$189K |
|
1194
Pinnacle West Capital
PNW
$12.2B
| $16.3M | ﹤0.01% |
218,871
-7,155
| -3% | -$548K |
|
|
LONA
1195
LeonaBio Inc
LONA
$73.9M
| $16.3M | ﹤0.01% |
+88,200
| New | +$14.7M |
|
|
CCRN
1196
DELISTED
Cross Country Healthcare
CCRN
| $16M | ﹤0.01% |
2,471,839
+6,000
| +0.2% | +$38K |
|
1197
Western Union
WU
$2.34B
| $15.9M | ﹤0.01% |
742,625
-49,643
| -6% | -$1.13M |
|
1198
Baker Hughes
BKR
$63B
| $15.8M | ﹤0.01% |
1,190,276
-36,643
| -3% | -$561K |
|
1199
IPG Photonics
IPGP
$3.57B
| $15.8M | ﹤0.01% |
92,960
-2,977
| -3% | -$491K |
|
1200
State Street Utilities Select Sector SPDR ETF
XLU
$22.9B
| $15.7M | ﹤0.01% |
528,508
-462,376
| -47% | -$13.7M |
|
Similar funds
T. Rowe Price Associates's Q3 2020 Portfolio in Review
As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
- T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
- T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
- T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
- T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
- T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.
Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.